Annexin A10/ANXA10 Antibody (Rabbit mAb) [J2G3]

CatNo: F8010

    Application: Reactivity:
    • Lane 1: BxPC-3, Lane 2: Mouse stomach, Lane 3: Rat stomach
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000
    1:2000
    Application
    WB, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    37 kDa 35 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human stomach tissue; Mouse stomach tissue; Rat stomach tissue; BxPC-3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Annexin A10/ANXA10 Antibody (Rabbit mAb) [J2G3] detects endogenous levels of total Annexin A10/ANXA10 protein.
    Uniprot ID
    Q9UJ72
    Clone
    J2G3
    Synonym(s)
    ANX14, ANXA10, Annexin A10, Annexin-10, Annexin-14
    Background
    Annexin A10 (ANXA10) is a calcium- and phospholipid-binding member of the annexin A family that shows tissue-restricted expression and functions as a regulator of epithelial differentiation and tumor progression in gastrointestinal and hepatobiliary tissues. The protein possesses the conserved annexin core of repeated annexin domains that mediate Ca²⁺‑dependent phospholipid association, together with a distinctive N‑terminal region that contributes to its nuclear localization in gastric epithelium and to interactions with signaling partners that control cell-cycle progression and survival. In normal adult liver, a short liver‑specific isoform (ANXA10S) is expressed, and down‑regulation of ANXA10S in hepatocellular carcinoma correlates with vascular invasion, early recurrence and poor prognosis, particularly when combined with p53 mutation, indicating that adequate ANXA10 expression restrains invasive growth and that loss of ANXA10 synergizes with p53 pathway disruption to accelerate tumor progression. In gastric mucosa across multiple species, ANXA10 protein is specifically expressed in fetal and adult gastric epithelium and Brunner’s glands, and is commonly lost in areas with intestinal metaplasia, marking it as a gastric differentiation marker whose presence distinguishes gastric‑type epithelium from metaplastic intestinal‑type mucosa. Immunohistochemical analysis of large gastric carcinoma cohorts shows ANXA10 expression in roughly half of tumors, with high prevalence in diffuse‑type and mixed‑type gastric carcinoma and much lower expression in intestinal‑type tumors; in diffuse‑type gastric carcinoma, ANXA10 positivity associates with lower tumor stage, reduced lymph‑node metastasis and better five‑year survival, whereas in intestinal‑type carcinoma ANXA10 expression correlates with higher stage and poorer survival, revealing subtype‑specific roles in tumor biology. In oral squamous cell carcinoma, ANXA10 mRNA and protein are upregulated relative to normal mucosa, and siRNA‑mediated knockdown reduces proliferation through inactivation of ERK signaling and G1 phase arrest accompanied by upregulation of cyclin‑dependent kinase inhibitors, identifying ANXA10 as an indicator and driver of tumor-cell proliferation via MAPK/ERK pathway modulation. Annexin A10 also influences apoptosis and stress responses in papillary thyroid carcinoma: ANXA10 and its binding partner TSG101 are upregulated in carcinoma cell lines, ANXA10 knockdown inhibits proliferation, promotes apoptosis and inactivates MAPK/ERK signaling, and these effects are reversed by TSG101 overexpression, demonstrating that ANXA10 binds TSG101 and maintains MAPK/ERK pathway activity to support thyroid tumor growth. Across pancreatic precursor lesions and invasive pancreatic ductal adenocarcinoma, ANXA10 is consistently overexpressed in ductal epithelial cells of PanINs, IPMNs and PDACs but absent in normal ducts and most chronic pancreatitis, and co‑expression with CD24 in high‑grade neoplasia correlates with progression toward PDAC, supporting its use as an early marker of ductal transformation and precursor lesion advancement. In colorectal and other cancers, ANXA10 knockdown has been reported to induce ferroptosis by interfering with autophagy-mediated TFRC degradation and to reduce metastasis by limiting EMT‑linked pathways such as PLA2G4A/PGE2/STAT3, further highlighting its mechanistic role in controlling proliferation, survival, migration and EMT via defined signaling axes.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください